Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Go Cibus
San Diego, California, United Statesbgp.tools ↗
- Ownership
- Private
- Employees
- ~159
- Development stage
- Other
01
Overview
Cibus develops and licenses non-transgenic gene-edited plant traits using its proprietary RTDS platform. Its products are designed to improve crop yields, reduce chemical inputs, and enable sustainable ingredient production. Traits developed by Cibus are indistinguishable from those produced by conventional breeding methods. The company operates the industry's first standardized high-throughput gene-editing facility.
- Modalities
- Gene editingNon-transgenic gene editing technology
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on Go Cibus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Go Cibus.